Get the Weekly Intelligence Brief — top committee picks every Sunday.

MIRM vs ZBH

Mirum Pharmaceuticals, Inc. vs Zimmer Biomet — AI-powered side-by-side comparison
MIRM
Mirum Pharmaceuticals, Inc.
56
Watch
VS
ZBH
Zimmer Biomet
69
Buy
MetricMIRMZBH
AI Score 56 69
Price $98.27 $97.22
P/E Ratio -6.75× 23.54×
ROE -7.4% 5.6%
Revenue Growth YoY
Gross Margin 81.7% 69.9%
Debt / Equity -72.97× 0.59×
Dividend Yield 0.0% 1.0%
RSI (14) 33.9 63.1
Beta 0.507 0.462
Expected Upside +3.7%

AI Committee View

Current Innellis committee reasoning for MIRM versus ZBH.
ZBH leads by 13 points.

ZBH scores 69/100 (Buy) versus MIRM at 56/100 (Watch).

MIRM Committee View
50% agreement
6 analysts

The committee is genuinely divided. Growth Analyst sees a compelling case — revenue growing 44.0% yoy -- genuine top-line momentum. Value Analyst remains cautious — price-to-book of 13.0x prices in significant intangible value. This disagreement is itself the signal — the setup is not clean in either direction.

Bull Case
  • Revenue growing 44.0% YoY -- genuine top-line momentum — Growth
  • VIX regime is low -- calm backdrop supports risk-taking — Macro
  • Market regime is bullish (Bull market -- normal position sizing) — Macro
Bear Case
  • Price-to-book of 13.0x prices in significant intangible value — Value
  • ROE of only -289.3% -- cheap may mean cheap for a reason — Value
  • MACD histogram negative -- bearish momentum — Technical
ZBH Committee View
80% agreement
5 analysts

The primary driver is vix regime is low -- calm backdrop supports risk-taking. The main limiting factor is daily trend (uptrend) conflicts with the weekly trend (downtrend) -- fighting the larger trend. The committee is constructive but not yet at full conviction.

Bull Case
  • Price-to-book of 1.4x is a discount to asset value — Value
  • 5 consecutive earnings beats -- consistent execution — Growth
  • Quarter-over-quarter growth rate is ACCELERATING, not just positive — Growth
Bear Case
  • Daily trend (uptrend) conflicts with the weekly trend (downtrend) -- fighting the larger trend — Technical
Want the full breakdown?
Committee votes, technicals, and trade plans for both companies.
MIRM Full Analysis ZBH Full Analysis